GENETIC INFORMATION PUBLICATION PRIOR TO PRACTICAL USE KNOWLEDGE COULD JEOPARDIZE FUTURE DRUG DEVELOPMENT OPPORTUNITIES -- HUMAN GENOME SCIENCE's HASELTINE
Executive Summary
Premature publication of gene sequencing information could jeopardize future development of therapies based on that research, Human Genome Sciences CEO William Haseltine maintained at an American Enterprise Institute meeting on genetic research in Washington, D.C. June 30.